Thus, while administration of either anti-IL11 or anti-TGFβ reduced fibrosis following AKI, anti-IL11 had singular effects to also attenuate inflammation and tubular damage while robustly preserving kidney function. This evidence concerns the gene IL11 and acute kidney injury.